SCHEMBL6386950

SCHEMBL6386950

O=C=Nc1ccc2c(cnn2C(=O)O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 1/20 0.42
▸ AURKA O14965 1/20 0.42
▸ DAPK3 O43293 1/20 0.42
▸ CSNK1A1 P48729 1/20 0.42
▸ GSK3A P49840 1/20 0.42
▸ LIMK1 P53667 1/20 0.42
▸ IKBKE Q14164 1/20 0.42
▸ MAPK14 Q16539 1/20 0.42
▸ TAOK1 Q7L7X3 1/20 0.42
▸ CLK4 Q9HAZ1 1/20 0.42
▸ DYRK1B Q9Y463 1/20 0.42
▸ SLC22A12 Q96S37 2/20 0.39
▸ MAPK1 P28482 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ MAPT P10636 2/20 0.36
▸ CYP3A4 P08684 2/20 0.35
▸ TRPA1 O75762 1/20 0.35
▸ KMT2A Q03164 1/20 0.34
▸ HSP90AB1 P08238 1/20 0.34
▸ SHMT2 P34897 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18038131 0.87 CHEK1 (0.41) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL6474362 0.80 ROCK2 (0.43) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL31691580 0.74 CHEK1 (0.49) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL15968896 0.74 CHEK1 (0.45) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL3638105 0.73 CHEK1 (0.47) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL878217 0.73 CHEK1 (0.73) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL952561 0.73 CHEK1 (0.47) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL3640657 0.73 CHEK1 (0.44) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL2474316 0.73 CYP11B2 (0.45) CHEK1AURKADAPK3CSNK1A1GSK3A
SCHEMBL28048800 0.71 CHEK1 (0.42) CHEK1AURKADAPK3CSNK1A1GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1608639-A2 NOVEL BICYCLIC UREA DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS Bayer Pharmaceuticals Corporation (US) 2005-12-28 — — EP disclosed
WO-2004078748-A2 NOVEL BICYCLIC UREA DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2004-09-16 — — WO disclosed
Send feedback